Skip to content

Investigator

Amir Mitchell

UNIV OF MASSACHUSETTS MED SCH WORCESTER · funded by NIAID, NIGMS

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Sep 1, 2019

Latest Jun 10, 2022.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Mechanisms underlying bacterial sensitivity to host-targeted drugs

    $923k

    Jun 10, 2022NIAIDUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11089532 (opens the source filing in a new tab)

  2. R35

    Interactions underlying resilient bacterial communities and successful colonization of host niches

    $461k

    Sep 1, 2019NIGMSUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11088457 (opens the source filing in a new tab)

  3. R35

    Interactions underlying resilient bacterial communities and successful colonization of host niches

    $461k

    Sep 1, 2019NIGMSUNIV OF MASSACHUSETTS MED SCH WORCESTERNIH RePORTER · 11332741 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources